VP Sales (BioTech)

TL;DR

VP Sales (BioTech): Owning commercial relationships with the world's largest biotech accounts and leading strategic enterprise sales cycles with an accent on high-value deal closure and market growth. Focus on building ROI frameworks for AI-driven patient engagement and navigating complex multi-stakeholder organizations in the healthcare AI sector.

Location: Remote (United States)

Company

Hippocratic AI is a leading generative AI company in healthcare, developing safety-focused LLMs designed to transform patient outcomes globally.

What you will do

• Drive end-to-end enterprise deals with commercial-stage biotech companies.
• Partner with Product, Clinical, and ML teams to develop use cases for patient support, drug adherence, and clinical trial recruitment.
• Build analytical ROI frameworks and consultative business cases for biotech buyers.
• Maintain strict pipeline discipline, accurate forecasting, and CRM hygiene.
• Represent the company at biotech conferences and industry events to build executive relationships.

Requirements

• Bachelor's degree required; advanced degree preferred.
• 10+ years of enterprise sales experience, including 5+ years selling to commercial-stage biotech or specialty pharma.
• Proven track record of closing enterprise deals valued between $500K and $2M+.
• Experience selling SaaS, consulting, or AI solutions with bespoke structuring.
• History of carrying a quota of approximately $3M ARR per year.
• Must be based in the United States

Nice to have

• Background in Investment Banking or management consulting.
• Existing relationships with commercial executives at commercial-stage biotech companies.
• Experience with digital health or AI-driven patient engagement programs.
• Experience working in high-growth healthcare technology startups or regulated industries.

Culture & Benefits

• Opportunity to be part of a category-creating company reinventing healthcare safety.
• Collaboration with a world-class team of AI pioneers, physicians, and researchers.
• Strong financial backing from leading AI and healthcare investors (Series C).
• Mission-driven focus on ethics, safety, and patient-centered outcomes.